Cowen Inc’s Bristol-Myers Squibb BMY Stock Holding History

Cowen Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$776K	Sell	646,800 -168,000	-21%	-$7.83M	0.06%	172
2019 Q1	$370K	Buy	+814,800	New	+$40.6M	0.04%	171
2017 Q2	–	Sell	-1,687	Closed	-$9.17M	–	311
2017 Q1	$9.17M	Buy	+1,687	New	+$92.5K	0.44%	36
2016 Q4	–	Sell	-45,000	Closed	-$2.43M	–	249
2016 Q3	$2.43M	Buy	+45,000	New	+$2.89M	0.14%	76

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cowen Inc's BMY Position: Q2 2019 in Review

Cowen Inc sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 16,200 shares — an estimated $755K sold.

Cowen Inc first reported a position in BMY in Q2 2013 and held it in 6 quarters. The position peaked at $3.7M in Q2 2013. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Cowen Inc reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
Cowen Inc sold 16,200 Bristol-Myers Squibb shares in Q2 2019, an estimated $755K.
Cowen Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 6 quarters.
Cowen Inc's Bristol-Myers Squibb position peaked at $3.7M in Q2 2013.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.